Insider Buy/Sell Details for the Biotechnology Industry — Last 30 Days
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1143)
Pharvaris N.V. (PHVS)
Schikan Johannes Gerardus Christiaan Petrus — Director
Shares
100
Price
$30.03
Total Value
$3.00K
Shares Held After
388,067
% of Holdings
0.0%
Pharvaris N.V. (PHVS)
Lesage Anne — Chief Early Development
Shares
100
Price
$30.03
Total Value
$3.00K
Shares Held After
56,450
% of Holdings
0.2%
Pharvaris N.V. (PHVS)
Lesage Anne — Chief Early Development
Shares
100
Price
$30.03
Total Value
$3.00K
Shares Held After
156,869
% of Holdings
0.1%
Pharvaris N.V. (PHVS)
Lu Peng — Chief Medical Officer
Shares
100
Price
$30.03
Total Value
$3.00K
Shares Held After
66,083
% of Holdings
0.2%
NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI)
Heshmatpour Amir F — Director
Shares
10,000
Price
$4.90
Total Value
$49.00K
Shares Held After
3,052,000
% of Holdings
0.3%
ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
Apel Daniel Joseph — Chief Financial Officer
Shares
8,730
Price
$71.92
Total Value
$627.86K
Shares Held After
162,905
% of Holdings
5.1%
ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
Apel Daniel Joseph — Chief Financial Officer
Shares
1,157
Price
$70.45
Total Value
$81.51K
Shares Held After
171,635
% of Holdings
0.7%
ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
Apel Daniel Joseph — Chief Financial Officer
Shares
3,208
Price
$70.11
Total Value
$224.91K
Shares Held After
172,792
% of Holdings
1.8%
Vor Biopharma Inc. (VOR)
RA CAPITAL MANAGEMENT, L.P. — Director
Shares
165,150
Price
$15.77
Total Value
$2.60M
Shares Held After
2,402,095
% of Holdings
6.4%
Adaptive Biotechnologies Corp (ADPT)
RUBINSTEIN JULIE — President and COO
Shares
19,060
Price
$14.13
Total Value
$269.32K
Shares Held After
390,808
% of Holdings
4.7%
Kymera Therapeutics, Inc. (KYMR)
Chadwick Jeremy G — Chief Operating Officer
Shares
300
Price
$90.00
Total Value
$27.00K
Shares Held After
61,202
% of Holdings
0.5%
RECURSION PHARMACEUTICALS, INC. (RXRX)
Gibson Christopher — Director
Shares
40,000
Price
$3.61
Total Value
$144.40K
Shares Held After
906,556
% of Holdings
4.2%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
12
Price
$90.08
Total Value
$1.08K
Shares Held After
674,944
% of Holdings
0.0%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
88
Price
$90.08
Total Value
$7.93K
Shares Held After
3,899,829
% of Holdings
0.0%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
5,900
Price
$89.96
Total Value
$530.76K
Shares Held After
0
% of Holdings
100.0%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
364
Price
$575.85
Total Value
$209.61K
Shares Held After
18,996
% of Holdings
1.9%
Pharvaris N.V. (PHVS)
Schikan Johannes Gerardus Christiaan Petrus — Director
Shares
7,000
Price
$30.05
Total Value
$210.38K
Shares Held After
388,167
% of Holdings
1.8%
Pharvaris N.V. (PHVS)
Lesage Anne — Chief Early Development
Shares
7,000
Price
$30.05
Total Value
$210.36K
Shares Held After
156,969
% of Holdings
4.3%
Pharvaris N.V. (PHVS)
Lesage Anne — Chief Early Development
Shares
7,000
Price
$30.05
Total Value
$210.36K
Shares Held After
56,450
% of Holdings
11.0%
Pharvaris N.V. (PHVS)
Lesage Anne — Chief Early Development
Shares
500
Price
$30.00
Total Value
$15.00K
Shares Held After
56,450
% of Holdings
0.9%
Pharvaris N.V. (PHVS)
Lu Peng — Chief Medical Officer
Shares
7,001
Price
$30.05
Total Value
$210.40K
Shares Held After
66,083
% of Holdings
9.6%
ProMIS Neurosciences Inc. (PMN)
Kirwin Patrick D. — Director
Shares
4,000
Price
$11.33
Total Value
$45.32K
Shares Held After
4,653
% of Holdings
86.0%
Axsome Therapeutics, Inc. (AXSM)
Maizel Ari — Chief Commercial Officer
Shares
7,500
Price
$182.42
Total Value
$1.37M
Shares Held After
0
% of Holdings
100.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
600
Price
$580.06
Total Value
$348.03K
Shares Held After
40,513
% of Holdings
1.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,099
Price
$579.08
Total Value
$636.41K
Shares Held After
41,113
% of Holdings
2.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,781
Price
$578.11
Total Value
$1.03M
Shares Held After
42,212
% of Holdings
4.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,707
Price
$576.98
Total Value
$984.91K
Shares Held After
43,993
% of Holdings
3.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,410
Price
$575.99
Total Value
$812.15K
Shares Held After
45,700
% of Holdings
3.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
736
Price
$574.86
Total Value
$423.09K
Shares Held After
47,110
% of Holdings
1.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,644
Price
$574.06
Total Value
$943.75K
Shares Held After
47,846
% of Holdings
3.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
523
Price
$572.48
Total Value
$299.41K
Shares Held After
49,490
% of Holdings
1.0%
Travere Therapeutics, Inc. (TVTX)
ROTE WILLIAM E. — Chief Research Officer
Shares
9,100
Price
$39.09
Total Value
$355.72K
Shares Held After
113,987
% of Holdings
7.4%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
21
Price
$173.04
Total Value
$3.63K
Shares Held After
10,666
% of Holdings
0.2%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
249
Price
$172.49
Total Value
$42.95K
Shares Held After
10,687
% of Holdings
2.3%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
257
Price
$171.62
Total Value
$44.11K
Shares Held After
10,936
% of Holdings
2.3%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
75
Price
$170.58
Total Value
$12.79K
Shares Held After
11,193
% of Holdings
0.7%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
105
Price
$169.52
Total Value
$17.80K
Shares Held After
11,268
% of Holdings
0.9%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
101
Price
$168.64
Total Value
$17.03K
Shares Held After
11,373
% of Holdings
0.9%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
141
Price
$167.42
Total Value
$23.61K
Shares Held After
11,474
% of Holdings
1.2%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
20
Price
$166.32
Total Value
$3.33K
Shares Held After
11,615
% of Holdings
0.2%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
31
Price
$165.70
Total Value
$5.14K
Shares Held After
11,635
% of Holdings
0.3%
SANGAMO THERAPEUTICS, INC (SGMO)
Davis Gregory D — Head of Research & Technology
Shares
69,827
Price
$0.25
Total Value
$17.69K
Shares Held After
115,284
% of Holdings
37.7%
Dyne Therapeutics, Inc. (DYN)
Kersten Dirk — Director
Shares
2,652
Price
$20.00
Total Value
$53.05K
Shares Held After
4,196,573
% of Holdings
0.1%
BioNTech SE (BNTX)
Poetting Sierk — Chief Operating Officer
Shares
50,000
Price
$110.56
Total Value
$5.53M
Shares Held After
399,387
% of Holdings
11.1%
Aditxt, Inc. (ADTX)
HRT FINANCIAL LP — 10% Owner
Shares
11,982
Price
$0.30
Total Value
$3.59K
Shares Held After
121,592
% of Holdings
9.0%
Nasus Pharma Ltd (NSRX)
Teleman Dan Benjamin — Director
Shares
2,900
Price
$3.76
Total Value
$10.90K
Shares Held After
156,991
% of Holdings
1.8%
Dyne Therapeutics, Inc. (DYN)
Rhodes Jason P — Director
Shares
59,663
Price
$19.68
Total Value
$1.17M
Shares Held After
1,285,704
% of Holdings
4.4%
Dyne Therapeutics, Inc. (DYN)
Rhodes Jason P — Director
Shares
1,485
Price
$19.68
Total Value
$29.22K
Shares Held After
11,663
% of Holdings
11.3%
Dyne Therapeutics, Inc. (DYN)
Rhodes Jason P — Director
Shares
150,942
Price
$19.68
Total Value
$2.97M
Shares Held After
5,260,179
% of Holdings
2.8%
Dyne Therapeutics, Inc. (DYN)
Rhodes Jason P — Director
Shares
75,866
Price
$19.68
Total Value
$1.49M
Shares Held After
1,738,617
% of Holdings
4.2%
Showing 301–350 of 1143 transactions (page 7 of 23)